North America Led Non-Surgical Bio Implants 2016 Analysis and Forecasts to 2022

(MENAFNEditorial) North America Led Non-Surgical Bio Implants 2016 Analysis and Forecasts to 2022

WiseGuyReports.com adds ''Non-Surgical Bio Implants Global market Outlook (2015-2022)'' new report to its research database.

PUNE INDIA May 2 2016 /EINPresswire.com/ -- According to Researcher the Global Non Surgical Bio Implants Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Rising aged population technological advancement in bio-implants high level of healthcare awareness and rising disposable incomes are the factors driving the non-surgical bio-implants market. However high treatment cost increasing application areas mostly medical and aesthetic for biomaterials used in non-surgical bio-implants and reimbursement issues are the factors hindering the market.

Complete Report Details Available at https://www.wiseguyreports.com/reports/456532/non-surgical-bio-implants-global-market-outlook .

Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region.

Some of the key players in the market include Novatex Bioengineering SA LCA Pharmaceuticals Moma Therapeutics Inc. Johnson & Johnson Kythera Pharmaceuticals Inc. Anika Therapeutics Inc. Fidia Farmaceutici FibroGen Inc. Hangzhou Gallop Biological Products Co. Ltd. Albiorex International BioPolymer GmbH & Co. KG Adoderm Nordic Aesthetics Teoxane Laboratoires and Coapt Systems.

Inquire more about this report at https://www.wiseguyreports.com/enquiry/456532/non-surgical-bio-implants-global-market-outlook .

Bio-implants Type Covered:

Injectable biomaterials: Hyaluronan Hydrogels Hyaluronic acid Collagen Calcium phosphate ceramic pastes Biopolymers Hydroxyapatite
Alloplastic biomaterials: Acrylic hydrogel
Non-surgical bio-implants: Viscoaugmentation bio-implants Viscosupplementation bio-implants
What report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments sub segments and the regional markets
- Market Trends (Drivers Constraints Opportunities Threats Challenges Investment Opportunities and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies financials and recent developments
- Supply chain trends mapping the latest technological advancements

Get a sample copy at https://www.wiseguyreports.com/sample_request/456532/non-surgical-bio-implants-global-market-outlook .

Major Points in Table of Content

1 Executive Summary

2 Preface

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Non-Surgical Bio-Implants Market By Bio-implants Type
5.1 Introduction
5.2 Injectable biomaterials
5.3 Alloplastic biomaterials
5.4 Non-surgical bio-implants

6 Global Non-Surgical Bio-Implants Market By Geography
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World

7 Key Developments
7.1 Agreements Partnerships Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies

8 Company Profiling
8.1 Novatex Bioengineering SA
8.2 LCA Pharmaceuticals
8.3 Moma Therapeutics Inc.
8.4 Johnson & Johnson
8.5 Kythera Pharmaceuticals Inc.
8.6 Anika Therapeutics Inc.
8.7 Fidia Farmaceutici
8.8 FibroGen Inc.
8.9 Hangzhou Gallop Biological Products Co. Ltd.
8.10 Albiorex International
8.11 BioPolymer GmbH & Co. KG
8.12 Adoderm
8.13 Nordic Aesthetics
8.14 Teoxane Laboratoires
8.15 Coapt Systems

Order a Purchase Report Copy https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456532 .